3750 — Cytori Cell Research Institute Income Statement

0.000.00%

Last trade - 00:00

FinancialsBalancedMicro CapSucker Stock

Annual income statement for Cytori Cell Research Institute, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,180	1,388	1,336	2,145	1,560
Cost of Revenue
Gross Profit	756	760	859	1,269	1,293
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	802	1,975	1,531	3,147	2,639
Operating Profit	378	-587	-195	-1,002	-1,078
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	319	-654	-65.3	-1,166	-1,011
Provision for Income Taxes
Net Income After Taxes	317	-775	-77.1	-1,060	139
Minority Interest
Net Income Before Extraordinary Items
Net Income	319	-832	-77.6	-1,060	138
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	319	-832	-77.6	-1,060	138
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.22	-108	-23.3	-98.4	-7.2
Dividends per Share